Medical City Healthcare announced that Mark Deno will be the CEO of the system’s McKinney hospital. He is succeeding Ernest Lynch, who retired after over 20 years. Before this role, Deno served as CEO of Medical City North Hills, where the hospital received multiple five-star ratings for various specialties. His tenure included advancements such as obtaining CAP accreditation for the laboratory and achieving recertification as an Advanced Primary Stroke Center. Deno holds an MBA from American Intercontinental University and a Bachelor’s in Business Administration from Colorado Technical University.
Texas Health Resources is ranked No. 3 on Fortune’s Best Workplaces in Texas list, marking the highest recognition for a healthcare system and North Texas-based organization. This acknowledgment, based on feedback from nearly 95,000 employees surveyed around the country, highlights Texas Health’s commitment to fostering a workplace where employees can thrive. CEO Barclay Berdan and Chief People Officer Carla Dawson emphasized the importance of diversity, inclusion, and a range of employee benefits in creating a positive work environment. Texas Health ranked No. 29 on Fortune’s 100 Best Companies to Work For list, maintaining its status as a top employer for the tenth consecutive year.
Tenet Healthcare Corporation reported a net income of $259 million, or $2.64 per diluted share, for the second quarter of 2024, with adjusted diluted earnings per share at $2.31. The company achieved a consolidated Adjusted EBITDA of $945 million, up 12.1 percent year-over-year, while Ambulatory Care Adjusted EBITDA increased by 20.8 percent to $447 million. The Board has authorized a new $1.5 billion share repurchase program, and the FY 2024 Adjusted EBITDA outlook has been raised to between $3.825 billion and $3.975 billion. CEO Saum Sutaria highlighted that the strong performance results from growth in volume and revenue, enhancing their patient-centered care strategy.
Verily has announced Lightpath1, a personalized chronic care solution aimed at addressing the needs of health plans and their members. With the first offering, Lightpath Metabolic, focused on cardiometabolic diseases. Set for open enrollment in early 2026, this solution will utilize expertise from Verily’s Onduo program, providing modular care that allows members to transition between different levels of support as needed. The program includes specialized offerings for diabetes management, weight loss, and long-term health monitoring, backed by a team of healthcare professionals and advanced technology. Verily’s initiative emphasizes the integration of AI to enhance personalized care experiences and promote health equity for individuals with chronic conditions.
Author
